Genus PLC Director/PDMR Shareholding

RNS Number : 7071E

Genus PLC

18 September 2024

 

18 September 2024

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting on 15 September 2024 of conditional nil-cost options granted in 2021 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table A below; and conditional nil-cost options granted in 2021 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table B below, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 16 September 2024 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the balance of ordinary shares.

 

Conditional nil-cost options granted under the PSP were subject to relevant performance conditions, measured over a three-year performance period which commenced on 1 July 2021 and ended on 30 June 2024. Following assessment of the performance conditions, the Remuneration Committee determined that  the awards would vest at 50% of the original grant and the balance of awards have lapsed.

 

Genus also announces that, further to the vesting on 15 September 2024 of conditional share awards granted in 2021 and 2022 under the PSP, as listed in table C below, Matt Culbertson, a member of GELT sold ordinary shares in Genus on 16 September 2024 on the London Stock Exchange, to offset income tax and social security liabilities due on the releases and retained the balance of ordinary shares. Conditional share awards were granted to Matt Culbertson under the PSP prior to him becoming a member of GELT.  These conditional share awards were not subject to company performance conditions.

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised, conditional share awards released, and ordinary shares sold on 16 September 2024.

 

For further information please contact:

 

Genus:

Cara Guedeney, Deputy Company Secretary                                      Tel: [phone]

Table A - GELT 2019 Performance Share Plan Exercise

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1.    Matt Culbertson 2.    Elena Rice 3.    Jerry Thompson 4.    Dan Hartley 5.    Angelle Rosata
2.	Reason for the notification
a.	Position/status	1.    Chief Operating Officer, Genus PIC 2.    Chief Scientific Officer 3.    Regional Director of ABS EMEA 4.    Group General Counsel & Company Secretary 5.    Chief Human Resources Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Genus plc
b.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Exercise of nil-cost options under the PSP
c.	Price(s) and volume(s)	Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s) Volume(s) 1.    0p 1,736 2.    0p 3,689 3.    0p 3,618 4.    0p 3,828 5.    0p 3,332
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 1.    0p 1,736 2.    0p 3,689 3.    0p 3,618 4.    0p 3,828 5.    0p 3,332 Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
e.	Date of the transaction	2024-09-16
f.	Place of the transaction	Outside a trading venue
5.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.
c.	Price(s) and volume(s)	Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s) Volume(s) 1.        1,969.0000p 729 2.        1,978.6804p 1,333 3.        1,956.8616p 1,525 4.        1,956.8565p 1,805 5.        1,939.0000p 1,249
d.	Aggregated information ·    Aggregated volume ·    Price	Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s) Volume(s) 1.        1,969.0000p 729 2.        1,978.6804p 1,333 3.        1,956.8616p 1,525 4.        1,956.8565p 1,805 5.        1,939.0000p 1,249
e.	Date of the transaction	2024-09-16
f.	Place of the transaction	London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Exercise

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1.    Matt Culbertson 2.    Elena Rice 3.    Jerry Thompson 4.    Dan Hartley 5.    Angelle Rosata
2.	Reason for the notification
a.	Position/status	1.    Chief Operating Officer Genus PIC 2.    Chief Scientific Officer 3.    Regional Director of ABS EMEA 4.    Group General Counsel & Company Secretary 5.    Chief Human Resources Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Genus plc
b.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Exercise of nil-cost options under the DSBP
c.	Price(s) and volume(s)	Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s) Volume(s) 1.    0p 1,185 2.    0p 1,163 3.    0p 1,121 4.    0p 1,195 5.    0p 1,045
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 1.    0p 1,185 2.    0p 1,163 3.    0p 1,121 4.    0p 1,195 5.    0p 1,045 Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
e.	Date of the transaction	2024-09-16
f.	Place of the transaction	Outside a trading venue
5.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.
c.	Price(s) and volume(s)	Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s) Volume(s) 1.        1,969.0000p 498 2.        1,980.9286p 420 3.        1,956.8541p 473 4.        1,956.8404p 564 5.        1,939.0000p 392
d.	Aggregated information ·    Aggregated volume ·    Price	Numbers 1 to 5 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s) Volume(s) 1.        1,969.0000p 498 2.        1,980.9286p 420 3.        1,956.8541p 473 4.        1,956.8404p 564 5.        1,939.0000p 392
e.	Date of the transaction	2024-09-16
f.	Place of the transaction	London Stock Exchange, Main Market (XLON)

 

 

Table C - GELT 2019 Performance Share Plan Release

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Matt Culbertson
2.	Reason for the notification
b.	Position/status	Chief Operating Officer Genus PIC
c.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
d.	Name	Genus plc
e.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
f.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each     GB0002074580
g.	Nature of the transaction	Release of conditional share awards under the PSP
h.	Price(s) and volume(s)	Price(s) Volume(s) 0p 1,487 0p 584
i.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 0p 1,487 0p 584
j.	Date of the transaction	2024-09-16
k.	Place of the transaction	Outside a trading venue
5.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Sale of shares arising from the release of conditional share awards under the PSP to offset income tax and social security liabilities due on the release.
c.	Price(s) and volume(s)	Price(s) Volume(s) 1,961.7409p 625 1,961.7409p 246
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 1,961.7409p 625 1,961.7409p 246
e.	Date of the transaction	2024-09-16
f.	Place of the transaction	London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHUWARRSNUKAAR